Skip to main content

Urban–rural disparities in hypertension prevalence, awareness, treatment, and control among Chinese middle-aged and older adults from 2011 to 2015: a repeated cross-sectional study

Abstract

Background

China has experienced a continuing increase in hypertension prevalence over the past few decades, especially in rural areas. The paper aims to examine the variation of urban–rural disparities in hypertension prevalence, awareness, treatment, and control among Chinese middle-aged and older adults between 2011 and 2015.

Methods

Our team extracted data from the China Health and Retirement Longitudinal Study (CHARLS), a nationally representative survey of residents aged 45 years and older. In this study, we used the 2011 wave and the 2015 wave of CHARLS. We calculated crude rates and age-adjusted rates of hypertension prevalence, awareness, treatment, and control for the general, urban, and rural populations in each wave and performed chi-square tests to examine urban–rural disparities. We used logistic regression to further confirm these disparities by controlling confounding factors in each wave. We then used generalized estimating equation (GEE) to further examine whether urban–rural disparities changed between 2011 and 2015.

Results

We included 11,129 records in the 2011 wave and 8916 records in the 2015 wave in this study. The mean age was 59.0 years and 5359 (48.2%) participants were male in the 2011 wave. Age-adjusted hypertension prevalence, awareness, treatment, control, and control among treated in the total population were 38.5%, 70.6%, 59.2%, 27.4%, and 46.4% in 2015. Urban–rural disparities in the indicators mentioned above were 5.7%, 13.4%, 15.3%, 9.4% and 5.6% in 2011; which decreased to 4.8%, 2.7%, 5.2%, 4.9% and 3.8% in 2015. Urban–rural disparities in prevalence, awareness and treatment were statistically significant in 2011 but not significant in 2015 adjusted for confounding factors, yet control disparities were statistically significant in both waves. Finally, urban–rural disparities in awareness and treatment had narrowed from 2011 to 2015.

Conclusions

Awareness, treatment, and control rates were sub-optimal among both urban and rural adults. Prevention and management of hypertension among both urban and rural adults should be further strengthened. Awareness and treatment increased more rapidly among rural adults, indicating some achievement had been made in enhancing the healthcare system in rural areas. More efforts are needed in attaining urban–rural equity of healthcare services.

Peer Review reports

Background

Hypertension, a leading risk factor for cardiovascular disease (CVD), is an important cause of disability and mortality worldwide [1, 2]. 31.1% of adults (1.39 billion) worldwide had hypertension in 2010 [3]. As the biggest developing country contributing to approximately 20% of the world’s population, China is experiencing a heavy disease burden of hypertension, which accounted for 14.28% of disability-adjusted life-years (DALYs) and 27.5% of deaths in 2013 [4]. The prevalence of hypertension in China has been increasing rapidly in the past few decades [5,6,7]. Notably, the rates of hypertension awareness, treatment, and control, important indicators that mirror the management abilities of the health care system, were still very low in China [8,9,10,11].

China has experienced rapid development since the market economy reform in 1978, which led to the transition of the traditional lifestyle, the increasing burden of non-communicable diseases was firstly concentrated in cities and then gradually spread to rural towns and villages [12]. With the rapid urbanization of rural areas, sedentary behaviors [13] and intake of high calorific value food [14] of rural residents have been continuing to increase. Hypertension prevalence in rural adults increased rapidly during the past few decades [15] and caught up with that of urban adults recently [8]. However, hypertension awareness, treatment, and control were always found to be lower among rural adults in China [8, 9, 16], which might mainly be due to the weak health system, poor healthcare human resources, and insufficient government investment in rural areas [17]. In 2009, a thorough reform of the national health care system was initiated to better manage non-communicable diseases (NCDs) and promote health equity [18]. For example, establishing a basic national public health service program (BNPHSP) was an important measure of this reform [10], which has made a great change to the prevention and management of non-communicable diseases in rural areas [19].

The development trend and urban–rural disparities of hypertension prevalence, awareness, treatment, and control among urban and rural adults after 2011 were not clear to date. This paper aims to compare the urban–rural differences in hypertension prevalence, awareness treatment, and control in 2011 and 2015, and whether their urban–rural difference has changed from 2011 to 2015 after the 2009 health system reform, to mirror the variation of urban–rural inequity in health care and draw public policy implications for further reform of health care systems.

Method

Data source

Data for this study was extracted from 2 waves (2011 and 2015) of the China Health and Retirement Longitudinal Study (CHARLS), an ongoing nationwide survey of residents aged 45 years and older from 28 provinces in China [20]. CHARLS was first collected in 2011 and then followed up every 2–3 years. Multistage stratified probability-proportionate-to-size (PPS) sampling was applied to generate a nationally representative sample in baseline, and a supplement sample was added in each follow-up wave to maintain the national representativeness of Chinese adults aged 45 years and older. A well-structured questionnaire was used and body examination was taken to collect demographic and health information in both waves. Further details of the CHARLS have been described elsewhere [20].

Participants

The original sample included 17,708 records in the 2011 wave and 21,097 adults in the 2015 wave. The inclusion criteria are as follows: (1) people who are not less than 45 years old; (2) people who reported whether had hypertension diagnosed by a doctor and reported whether being taking anti-hypertensive medication; (3) people who measured blood pressure 3 times; (4) people with no missing data of covariates.

Variables

The main outcome variables of this study were hypertension prevalence, awareness, treatment, and control. The systolic blood pressure (SBP) and diastolic blood pressure (DBP) of each respondent were recorded 3 times in the sitting position by a trained nurse using an HEM-7112 electronic monitor (Omron, Kyoto, Japan). The mean of the 3 readings was recorded as their BP values. Hypertension was defined as mean SBP ≥ 140 mmHg and/or mean DBP ≥ 90 mmHg and/or self-report taking anti-hypertensive medication currently. Hypertensive respondents who answered “yes” to the question “have you been diagnosed with hypertension by a doctor?” were defined as aware of hypertension. Hypertensive respondents who claimed currently taking antihypertensive medication were defined as treated. Hypertensive respondents who had a mean SBP of < 140 mmHg and a mean DBP of < 90 mmHg were defined as controlled [10, 21].

This study’s major independent variable of interest is urban/rural, which indicates whether a respondent belongs to urban or rural registration. A specific national administrative household registration system called “hukou” was originally designed to prohibit population migration in 1958 in China [22]. Hundreds of millions of rural workers have migrated to urban areas since the Chinese market-oriented reforms launched in the 1990s. By 2017, there were 286.5 million rural-to-urban migrant workers in China [23], which contribute to about one-fifth of China’s total population, but very few of them could get an urban hukou [22]. Residents holding an urban hukou not only have better chances in the labor market, but also can get numerous social security benefits such as housing subsidies, retirement allowances, unemployment insurance, and health insurance [10, 15, 22].

We controlled demographic and socioeconomic variables of this study including sex, age (categorized into 45–54, 55–64, 65–74, and ≥ 75), region (categorized into eastern, central, and western), marital status (categorized into married/partnered, and not partnered), education (categorized into illiterate, primary school and below, and secondary school and above), and household consumption per capita (the whole sample were ranked by household consumption per capita and were divided into 5 quintiles in each year to indicate relative economic level) [8, 15]. We also controlled some risk factors of hypertension such as smoke (classified into never, quit, current), drink (classified into never, quit, current), and body-mass-index(BMI) group (classified into < 24, 24–28, ≥ 28 kg/m2 according to Chinese standard [24], [25, 26].

Statistical analysis

We carried out descriptive statistics and multivariate regression in this study. Data analyses were conducted using STATA 16.0 and R4.1.1.

Descriptive statistics for all covariates of total, urban and rural adults were presented as proportions in each year. We reported numbers of adults, crude rate, and age-adjusted rate of hypertension prevalence, awareness, treatment control, and control among treated hypertensive adults by total, urban and rural. We used the chi-square test was used to examine whether there were statistical differences between urban and rural adults, with p-values presented.

Logistic regression in each wave was adopted to investigate whether urban–rural disparities of prevalence, awareness, treatment, control, and control among treated hypertensive adults existed in each wave after controlling for covariates. The model was specified as: ln \((\frac{{P_{i} }}{{1 - P_{i} }})\) = β0 + β1rural + βiXi + u. Pi was the probability of hypertension prevalence, awareness, treatment, or control; rural was the dummy for hukou type; Xi were covariates. Odds ratios were reported.

To explore whether urban–rural disparities of prevalence, awareness, treatment, control, and control among treated hypertensive adults had changed between 2011 and 2015, we adopted generalized estimating equation (GEE) regression for longitudinal data[27], of which the link function was set as “logit”. Differences in urban–rural disparities changed between 2011 and 2015 were examined by adding an interaction term of urban/rural and wave dummy variable. The model was specified as: ln \((\frac{{P_{i} }}{{1 - P_{i} }})\) = β0 + β1rural + β22015wave + δ1rural*2015wave + βiXi + u. Pi was the probability of hypertension prevalence, awareness, treatment, or control; rural was the dummy variable for urban/rural; wave was the dummy variable for wave; rural*2015wave was an interaction term of urban/rural and wave dummy variable; Xi were covariates. β1 captured the effect of rural hukou on outcome indicators in the 2011 wave; β2 captured the change of outcome indicators from 2011 to 2015 in urban adults; δ1 captured the change of urban–rural disparity of outcome indicators between the 2 waves; (β1 + δ1) captured the effect of rural hukou on outcome indicators in the 2015 wave. Odds ratios were reported.

Results

Descriptive study

The final sample included in this study were 11,129 records in the 2011 wave and 8916 records in the 2015 wave. The distribution of demographic characteristics is displayed in Table 1. In the 2011 wave, the mean age of all participants was 59.0 years, 5359 (48.2%) participants were male, and 5770 (51.8%) participants were female. Urban adults contributed to approximately 20% of the whole sample (2103/11,129 in the 2011 wave, 1591/8916 in the 2015 wave). Socioeconomic status is distributed differently among urban and rural adults. For example, the highest education level group and economic level group contributed to 60.7% and 40.8% of the whole sample among urban adults, while only 24.5% and 15.0% of the whole sample among rural adults in the 2011 wave.

Table 1 Demographic Characteristics of study population [n(%)]

Table 2 reports hypertension prevalence, awareness, treatment, and control grouped by urban/rural and waves. Age-adjusted hypertension prevalence, awareness, treatment, control, and control among treated in the total population were 38.5%, 70.6%, 59.2%, 27.4%, and 46.4% in 2015. The rate of awareness, treatment, control, and control among treated patients increased from 2011 to 2015 among both urban and rural adults. Urban–rural gaps of age standard rates of prevalence, awareness, treatment, control and control among treated patients were 5.7%, 13.4%, 15.3%, 9.4% and 5.6% in 2011; and had decreased to 4.8%, 2.7%, 5.2%, 4.9%, and 3.8% in 2015. Chi-square tests showed that prevalence, awareness, treatment control, and control among treated patients with hypertension were higher among urban adults than rural adults in both waves (p < 0.05).

Table 2 Prevalence, awareness, treatment, and control among the study population

Logistic regression analysis

The effects of the hukou dummy variable in Tables 3 and 4 present the logistic regression estimates of urban–rural disparities of hypertension prevalence, awareness, treatment, and control adjusted for all covariates in each wave. Rural adults were less likely to be hypertensive in both waves, but this trend is only statistically significant in the 2011 wave (OR 0.817, 95% CI 0.729–0.916) while not statistically significant in the 2015 wave (OR 0.933, 95% CI 0.822–1.060). The probabilities of awareness, treatment, and control among rural hypertensive adults were also lower than urban counterparts in both waves, but the disparities of awareness (OR 0.932, 95% CI 0.754–1.149) and treatment (OR 0.844, 95% CI 0.694–1.024) in 2015 wave were not statistically significant. The difference of control among hypertensive adults in treatment was not evident between urban and rural adults.

Table 3 Logistic regression estimates of hypertension prevalence and awareness [Odds Ratio(95%CI)]
Table 4 Logistic regression estimates of hypertension treatment and control [Odds Ratio(95%CI)]

Generalized estimating equation (GEE) analysis

Variations of urban–rural disparities in hypertension prevalence, awareness, treatment, and control from 2011 to 2015 were represented by the interaction term of urban/rural and wave in GEE analysis and were shown in Table 5. It can be discovered that the urban–rural disparities of hypertension awareness (OR 1.291, 95% CI 1.010–1.651) and treatment (OR 1.330, 95% CI 1.053–1.680) had significantly narrowed.

Table 5 GEE regression estimates of hypertension prevalence, awareness, treatment, and control [Odds Ratio(95%CI)]

Discussion

Overall, this study found that rural adults had lower hypertension prevalence, awareness, treatment, and control in both waves. However, urban–rural gaps in hypertension awareness and treatment had evidently narrowed from 2011 to 2015, and urban–rural disparities in prevalence, awareness, and treatment were not statistically significant after controlling for confounding factors in the 2015 wave.

This study found that the prevalence of hypertension was higher among urban adults in both waves among Chinese adults aged 45 years old and above, a conclusion similar to most studies of low-income countries [28,29,30,31] but opposite to that of high-income countries [28]. In China, hypertension prevalence was lower among rural adults than urban counterparts between 1990 and 2010 [5, 15], while some recently published studies found that the prevalence of rural adults was almost the same as [9] or even higher than that of urban adults [8, 32,33,34]. A possible explanation is these studies were either based on adults of all ages or not nationally representative, but the rapid increase of hypertension prevalence among rural adults always needs to pay attention to [15].

This study also found that the rates of awareness, treatment, and control were higher among urban adults, which is in accordance with most existing studies of China [15, 33, 35] and some low-income and middle-income countries [28, 36, 37]. With the unbalanced development between urban and rural areas since 1978, the gap in the healthcare system between urban and rural areas has widened [38], as well as the health care human resources. In 2011, there were 7.10 and 3.19 health professionals per 1000 population in urban areas and rural areas, respectively [39]. Some rural residents had to cover a long distance to seek for medical service. Besides, one’s urban/rural registration largely determined the type of medical insurance to be covered. Rural residents were mostly covered by New Cooperative Medical System (NCMS) [40], and rural hypertensive patients could hardly get reimbursement for outpatient services. By contrast, urban employees covered by Urban Employee Basic Medical Insurance (UEBMI) could get adequate reimbursement for hypertension outpatient services [27, 41]. Less access to medical services and higher cost for outpatient services might be the main reasons that awareness, treatment, and control rates were higher among urban adults.

Nevertheless, the logistic analysis found that urban–rural disparities in hypertension awareness and treatment were not evident in 2015, and the GEE analysis showed these disparities narrowed significantly between 2 waves. In other words, awareness and treatment of rural adults increased faster than urban counterparts from 2011 to 2015, which indicated that urban–rural equity in hypertension management has been promoted. The primary health care system was getting stronger during this period and primary health care became more available and affordable in rural areas [21]. BNPHSP might make a great contribution because it serves to provide free blood pressure testing for permanent residents aged above 35 at their first visit to primary health care institutions [40]. People who were diagnosed with hypertension were directly included in hypertension management, and at least 4 face-to-face follow-up visits were required to provide for these patients per year. Studies demonstrated that BNPHSP had effectively improved the awareness, treatment, and control of hypertension [19, 42]. Rural residents were more likely to get BNPHSP and had higher effective follow-up rate compared with urban adults is a possible explanation of why these indicators increased faster among rural adults [39].

Although hypertension awareness, treatment, and control increased from 2011 to 2015, the overall rates of awareness, treatment, and control were still very low in both waves. Compared with developed countries, such as the United States, Korea, and Canada [43, 44], China still has a long way to enhance hypertension management. Efforts are still needed to be made to further improve hypertension management, especially in rural adults. Measures, such as strengthening the healthcare human resources, improving the quality of medical services, promoting public awareness programs, implementing health poverty alleviation programs, add access to affordable drugs, could be taken [8].

In accordance with some previous studies, BMI had a positive effect on hypertension awareness, treatment, and control [35, 45, 46]. Since BMI is a well-known risk factor for hypertension, overweight and obese adults might pay more attention to the management of hypertension [46]. Besides, current drinkers had less possibility of awareness, treatment, and control of hypertension. In addition, the richest adults had higher rates of hypertension awareness, treatment, and control than the poorest adults, which might be because richer people obtain more opportunities to be taught health-related knowledge [47], and poorer people have more difficulties to seek for medical services or persist taking medicine owing to unaffordable expenditure [48]. Free health examination and affordable hypertension management should be further provided to those poor residents.

The strengths of the present study included: First, the data we used is nationally representative and more up-to-date than most existing studies exploring urban–rural disparities in hypertension prevalence and management. Second, repeated cross-sectional survey designs were conducted in the present study using two waves of data to reveal the variation of urban–rural disparities in hypertension prevalence and management.

There are some limitations to this study. First, CHARLS is representative of Chinese adults ≥ 45 years rather than all Chinese adults. Second, excluding records with missing data on blood pressure tests may cause an overestimation of hypertension prevalence, for participants who refused to take body examination might be healthier than others. Third, a part of participants who refused to report household consumption were more likely to be urban rich residents, among which the awareness, treatment, and control rates were relatively high, so it could cause underestimation of urban–rural disparities in these indicators. Finally, only data from 2 waves had been used in this study, which might not fully reflect the trend of hypertension prevalence and management after the 2009 primary-care reform.

In conclusion, hypertension awareness, treatment, and control increased from 2011 to 2015, especially among rural adults, reflecting that the government of China had made an effort to achieve urban–rural equity in hypertension management. However, efforts are still needed to be made to enhance the management of hypertension, which was of a great distance from that of some developed countries. Besides, urban–rural inequity in hypertension management still exists. Residents with rural hukou, especially those with low economic status, should be given more care in hypertension management. Further policies, such as reforming the hukou system, making hypertension covered by all health insurance, and promoting blood pressure screening and health education programs in rural areas, could be implemented.

Availability of data and materials

The datasets generated and analyzed during the current study are publicly available in the CHARLS website [http://charls.pku.edu.cn].

References

  1. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018, 392(10159):1736–1788.

  2. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018, 392(10159):1923–1994.

  3. Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020;16(4):223–37.

    Article  CAS  Google Scholar 

  4. Forouzanfar MH, Alexander L, Anderson HR, Bachman VF, Biryukov S, Brauer M, Burnett R, Casey D, Coates MM, Cohen A, et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(10010):2287–323.

    Article  Google Scholar 

  5. Guo J, Zhu YC, Chen YP, Hu Y, Tang XW, Zhang B. The dynamics of hypertension prevalence, awareness, treatment, control and associated factors in Chinese adults: results from CHNS 1991–2011. J Hypertens. 2015;33(8):1688–96.

    Article  CAS  Google Scholar 

  6. Wang X, Bots ML, Yang F, Hoes AW, Vaartjes I. Prevalence of hypertension in China: a systematic review and meta-regression analysis of trends and regional differences. J Hypertens. 2014;32(10):1919–27.

    Article  CAS  Google Scholar 

  7. Xi B, Liang Y, Reilly KH, Wang Q, Hu Y, Tang W. Trends in prevalence, awareness, treatment, and control of hypertension among Chinese adults 1991–2009. Int J Cardiol. 2012;158(2):326–9.

    Article  Google Scholar 

  8. Lu J, Lu Y, Wang X, Li X, Linderman GC, Wu C, Cheng X, Mu L, Zhang H, Liu J, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from 1.7 million adults in a population-based screening study (China PEACE Million Persons Project). Lancet. 2017;390(10112):2549–58.

    Article  Google Scholar 

  9. Li YC, Yang L, Wang LM, Zhang M, Huang ZJ, Deng Q, Zhou MG, Chen ZM, Wang LH. Burden of hypertension in China: A nationally representative survey of 174,621 adults. Int J Cardiol. 2017;227:516–23.

    Article  Google Scholar 

  10. Feng XL, Pang M, Beard J. Health system strengthening and hypertension awareness, treatment and control: data from the China Health and Retirement Longitudinal Study. Bull World Health Organ. 2014;92(1):29–41.

    Article  Google Scholar 

  11. Wang J, Zhang L, Wang F, Liu L, Wang H. Prevalence, awareness, treatment, and control of hypertension in China: results from a national survey. Am J Hypertens. 2014;27(11):1355–61.

    Article  CAS  Google Scholar 

  12. Howard AG, Attard SM, Herring AH, Wang H, Du S, Gordon-Larsen P. Socioeconomic gradients in the Westernization of diet in China over 20 years. SSM Popul Health. 2021;16: 100943.

    Article  Google Scholar 

  13. Wang J, Wang Y, Korivi M, Chen X, Zhu R. Status of sedentary time and physical activity of rural residents: a cross-sectional population-based study in Eastern China. Front Public Health 2022;10.

  14. Kun P, Liu Y, Pei X, Luo H. Regional and urban-rural disparities in prevalence of over-weight among old people in China: evidence from four Chinese provinces. J Nutr Health Aging. 2013;17(10):859–64.

    Article  CAS  Google Scholar 

  15. Li J, Shi L, Li S, Xu L, Qin W, Wang H. Urban-rural disparities in hypertension prevalence, detection, and medication use among Chinese Adults from 1993 to 2011. Int J Equity Health. 2017;16(1):50.

    Article  CAS  Google Scholar 

  16. Bundy JD, He J. Hypertension and related cardiovascular disease burden in China. Ann Glob Health. 2016;82(2):227–33.

    Article  Google Scholar 

  17. Zhou D, Feng Z, He S, Sun X, Ma C, Lv B, Zou X. Equity of the essential public health service in rural china: evidence from a nationwide survey of hypertensive patients. Pak J Med Sci. 2013;29(4):1012–7.

    Article  Google Scholar 

  18. Yip W, Fu H, Chen AT, Zhai T, Jian W, Xu R, Pan J, Hu M, Zhou Z, Chen Q, et al. 10 years of health-care reform in China: progress and gaps in Universal Health Coverage. Lancet. 2019;394(10204):1192–204.

    Article  Google Scholar 

  19. Zhang D, Pan X, Li S, Liang D, Hou Z, Li Y, Shi L. Impact of the National Essential Public Health Services Policy on Hypertension Control in China. Am J Hypertens. 2017;31(1):115–23.

    Article  Google Scholar 

  20. Zhao Y, Hu Y, Smith JP, Strauss J, Yang G. Cohort profile: the China Health and Retirement Longitudinal Study (CHARLS). Int J Epidemiol. 2014;43(1):61–8.

    Article  Google Scholar 

  21. Hou Z, Meng Q, Zhang Y. Hypertension prevalence, awareness, treatment, and control following China’s Healthcare Reform. Am J Hypertens. 2016;29(4):428–31.

    Article  Google Scholar 

  22. Song Y. What should economists know about the current Chinese hukou system? China Econ Rev. 2014;29:200–12.

    Article  Google Scholar 

  23. Ministry of Human Resources and Social Security of the People's Republic of China. 2018 Statistical Bulletin on the Development of Human Resources and Social Security. 2022. http://www.mohrss.gov.cn/SYrlzyhshbzb/zwgk/szrs/tjgb/201906/W020190611539807339450.pdf. Accessed 26th May 2022.

  24. Zhou B. Predictive values of body mass index and waist circumference to risk factors of related diseases in Chinese adult population. Zhonghua Liu Xing Bing Xue Za Zhi. 2002;23(1):5–10.

    PubMed  Google Scholar 

  25. Song H, Feng D, Wang R, Yang J, Li Y, Gao J, Wang Z, Yan Z, Long C, Zhou J, et al. The urban-rural disparity in the prevalence and risk factors of hypertension among the elderly in China-a cross-sectional study. PeerJ. 2019;7:e8015.

    Article  Google Scholar 

  26. Zhao Y, Atun R, Oldenburg B, McPake B, Tang S, Mercer SW, Cowling TE, Sum G, Qin VM, Lee JT. Physical multimorbidity, health service use, and catastrophic health expenditure by socioeconomic groups in China: an analysis of population-based panel data. Lancet Glob Health. 2020;8(6):e840–9.

    Article  Google Scholar 

  27. Liu JA, Shi LZ, Meng QY, Khan MM: Income-related inequality in health insurance coverage: analysis of China Health and Nutrition Survey of 2006 and 2009. Int J Equity Health 2012;11.

  28. Chow CK, Teo KK, Rangarajan S, Islam S, Gupta R, Avezum A, Bahonar A, Chifamba J, Dagenais G, Diaz R, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA. 2013;310(9):959–68.

    Article  CAS  Google Scholar 

  29. Sani RN, Connelly PJ, Toft M, Rowa-Dewar N, Delles C, Gasevic D, Karaye KM. Rural–urban difference in the prevalence of hypertension in West Africa: a systematic review and meta-analysis. J Hum Hypertens. 2022.

  30. Tateyama Y, Techasrivichien T, Musumari PM, Suguimoto SP, Ongosi AN, Zulu R, Dube C, Ono-Kihara M, Kihara M. Hypertension, its correlates and differences in access to healthcare services by gender among rural Zambian residents: a cross-sectional study. BMJ Open. 2022;12(4):e055668.

    Article  Google Scholar 

  31. Reddy SP, Mbewu AD, Williams DR, Harriman NW, Sewpaul R, Morgan JW, Sifunda S, Manyaapelo T, Mabaso M. Race, geographical location and other risk factors for hypertension: South African National Health and Nutrition Examination Survey 2011/12. SSM Popul Health. 2021;16:100986.

    Article  Google Scholar 

  32. Xing L, Jing L, Tian Y, Lin M, Du Z, Yan H, Ren G, Dong Y, Sun Q, Liu S. Urban–rural disparities in status of hypertension in northeast China: a population-based study, 2017–2019. Clin Epidemiol. 2019;11:801–20.

    Article  Google Scholar 

  33. Li W, Gu H, Teo KK, Bo J, Wang Y, Yang J, Wang X, Zhang H, Sun Y, Jia X, et al. Hypertension prevalence, awareness, treatment, and control in 115 rural and urban communities involving 47 000 people from China. J Hypertens. 2016;34(1):39–46.

    Article  Google Scholar 

  34. Zhang M, Wu J, Zhang X, Hu CH, Zhao ZP, Li C, Huang ZJ, Zhou MG, Wang LM. Prevalence and control of hypertension in adults in China, 2018. Zhonghua Liu Xing Bing Xue Za Zhi. 2021;42(10):1780–9.

    CAS  PubMed  Google Scholar 

  35. Lei XY, Yin NN, Zhao YH. Socioeconomic status and chronic diseases: the case of hypertension in China. China Econ Rev. 2012;23(1):105–21.

    Article  Google Scholar 

  36. Mohanty SK, Pedgaonkar SP, Upadhyay AK, Kämpfen F, Shekhar P, Mishra RS, Maurer J, O’Donnell O. Awareness, treatment, and control of hypertension in adults aged 45 years and over and their spouses in India: A nationally representative cross-sectional study. PLoS Med. 2021;18(8):e1003740.

    Article  Google Scholar 

  37. Yusufali AM, Khatib R, Islam S, Alhabib KF, Bahonar A, Swidan HM, Khammash U, Alshamiri MQ, Rangarajan S, Yusuf S. Prevalence, awareness, treatment and control of hypertension in four Middle East countries. J Hypertens. 2017;35(7):1457–64.

    Article  CAS  Google Scholar 

  38. Tang S, Meng Q, Chen L, Bekedam H, Evans T, Whitehead M. Tackling the challenges to health equity in China. Lancet. 2008;372(9648):1493–501.

    Article  Google Scholar 

  39. Niu H, Tian M, Ma A, Wang C, Zhang L. Differences and determinants in access to essential public health services in China: a case study with hypertension people and under-sixes as target population. Chin Med J (Engl). 2014;127(9):1626–32.

    Google Scholar 

  40. Feng XL. Undiagnosed and uncontrolled chronic conditions in China: Could social health insurance consolidation make a change? Med Care Res Rev. 2018;75(4):479–515.

    Article  Google Scholar 

  41. Qingyue M YH, Wen C, Qiang S, Xiaoyun L. People’s republic of China health system review. Manila: World Health Organization. Regional Office for the Western Pacific; 2015.

  42. Qin J, Zhang Y, Fridman M, Sweeny K, Zhang L, Lin C, Mao L. The role of the Basic Public Health Service program in the control of hypertension in China: Results from a cross-sectional health service interview survey. PLoS ONE. 2021;16(6):e0217185.

    Article  CAS  Google Scholar 

  43. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet 2021; 398(10304):957–980.

  44. Nwankwo T, Yoon SS, Burt V, Gu Q. Hypertension among adults in the United States: National Health and Nutrition Examination Survey, 2011–2012. NCHS Data Brief. 2013;133:1–8.

    Google Scholar 

  45. Liu X, Gu W, Li Z, Lei H, Li G, Huang W. Hypertension prevalence, awareness, treatment, control, and associated factors in Southwest China: an update. J Hypertens. 2017;35(3):637–44.

    Article  CAS  Google Scholar 

  46. Zhou J, Fang S. Association between Undiagnosed Hypertension and Health Factors among Middle-Aged and Elderly Chinese Population. Int J Environ Res Public Health. 2019;16(7):1214.

    Article  Google Scholar 

  47. Rahman M. H SE, Islam MJ, Mostofa MG, Saadat KA: Association of socioeconomic status with diagnosis, treatment and control of hypertension in diabetic hypertensive individuals in Bangladesh: a population-based cross-sectional study. JRSM Open. 2015;6(10):2054270415608118.

    Article  Google Scholar 

  48. Tang X, Xie X, Rao Z, Zheng Z, Hu C, Li S, Hu Z. Spatial analysis and comparison of the economic burden of common diseases: an investigation of 5.7 million rural elderly inpatients in Southeast China, 2010–2016. Front Public Health. 2021;9:774342.

    Article  Google Scholar 

Download references

Acknowledgements

We gratefully acknowledge the China Health and Retirement Longitudinal Study (CHARLS) team for providing data and the training in using the datasets. We thank the teachers who gave advisories and students who participated in the survey for their cooperation.

Funding

Not applicable.

Author information

Authors and Affiliations

Authors

Contributions

HC, XM, and XL conceptualized the study design. HC, YG, and HT participated in the data analysis. HC, XM, and XL participated in writing and revising the manuscript. All authors approved the final version of the manuscript.

Corresponding author

Correspondence to Xiaoyun Liu.

Ethics declarations

Ethics approval and consent to participate

CHARLS was approved by the Biomedical Ethics Review Committee of Peking University, and the ethical approval number was IRB00001052-11015. All procedures were in accordance with the ethical standards of the Helsinki Declaration. Participants provided informed consent before data collection.

Consent for publication

Not applicable.

Competing interests

The authors declare no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cheng, H., Gu, Y., Ma, X. et al. Urban–rural disparities in hypertension prevalence, awareness, treatment, and control among Chinese middle-aged and older adults from 2011 to 2015: a repeated cross-sectional study. BMC Cardiovasc Disord 22, 319 (2022). https://doi.org/10.1186/s12872-022-02769-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12872-022-02769-5

Keywords